PD合并部分难治性腹膜炎患者腹膜导管的同时切除和置换。

IF 1.7 3区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Luca Nardelli, Antonio Scalamogna, Federica Tripodi, Carlo Alfieri, Giuseppe Castellano
{"title":"PD合并部分难治性腹膜炎患者腹膜导管的同时切除和置换。","authors":"Luca Nardelli, Antonio Scalamogna, Federica Tripodi, Carlo Alfieri, Giuseppe Castellano","doi":"10.1177/11297298251372318","DOIUrl":null,"url":null,"abstract":"<p><p>In patients on peritoneal dialysis (PD) peritonitis continues to be the main cause of PD-related death, and the leading reason of transfer to hemodialysis (HD). International guidelines recommend that peritoneal catheter should be removed if PD effluent does not clear after 5 days of adequate antibiotics defining the case as refractory peritonitis. The simultaneous removal and replacement of the peritoneal catheter (SCR) has been used as treatment for recurrent or catheter-related peritonitis after the utter healing of the acute infection to spare patient the interruption of PD and the transfer to HD. On the other hand, in case of refractory episodes the employment of SCR is discouraged. However, the clinical trend of refractory peritonitis is not homogenous: some episodes are totally unresponsive to medical therapy, while others show to be partially responsive. Thus, the treatment should be diversified according to the different clinical evolution. We report two cases of refractory peritonitis sustained by P. aeruginosa that were successfully treated by SCR after a partial response to antibiotic therapy. Along with these preliminary data, we propose a novel therapeutical algorithm differentiating between complete refractory peritonitis and partial refractory peritonitis.</p>","PeriodicalId":56113,"journal":{"name":"Journal of Vascular Access","volume":" ","pages":"11297298251372318"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Simultaneous removal and replacement of the peritoneal catheter in PD patients with partial refractory peritonitis.\",\"authors\":\"Luca Nardelli, Antonio Scalamogna, Federica Tripodi, Carlo Alfieri, Giuseppe Castellano\",\"doi\":\"10.1177/11297298251372318\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In patients on peritoneal dialysis (PD) peritonitis continues to be the main cause of PD-related death, and the leading reason of transfer to hemodialysis (HD). International guidelines recommend that peritoneal catheter should be removed if PD effluent does not clear after 5 days of adequate antibiotics defining the case as refractory peritonitis. The simultaneous removal and replacement of the peritoneal catheter (SCR) has been used as treatment for recurrent or catheter-related peritonitis after the utter healing of the acute infection to spare patient the interruption of PD and the transfer to HD. On the other hand, in case of refractory episodes the employment of SCR is discouraged. However, the clinical trend of refractory peritonitis is not homogenous: some episodes are totally unresponsive to medical therapy, while others show to be partially responsive. Thus, the treatment should be diversified according to the different clinical evolution. We report two cases of refractory peritonitis sustained by P. aeruginosa that were successfully treated by SCR after a partial response to antibiotic therapy. Along with these preliminary data, we propose a novel therapeutical algorithm differentiating between complete refractory peritonitis and partial refractory peritonitis.</p>\",\"PeriodicalId\":56113,\"journal\":{\"name\":\"Journal of Vascular Access\",\"volume\":\" \",\"pages\":\"11297298251372318\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Vascular Access\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/11297298251372318\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Access","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/11297298251372318","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

在腹膜透析(PD)患者中,腹膜炎仍然是PD相关死亡的主要原因,也是转移到血液透析(HD)的主要原因。国际指南建议,如果PD排出物在给予足够的抗生素治疗5天后仍未清除,则应拔除腹膜导管,并将其定义为难治性腹膜炎。腹膜导管(SCR)的同时移除和更换已被用于治疗急性感染完全愈合后复发性或导管相关性腹膜炎,以避免患者PD中断和转移到HD。另一方面,在难治性发作的情况下,不鼓励使用SCR。然而,难治性腹膜炎的临床趋势并不均匀:一些发作对药物治疗完全无反应,而另一些发作则表现出部分反应。因此,治疗应根据不同的临床进展而多样化。我们报告两例难治性腹膜炎由铜绿假单胞菌持续,成功地通过SCR治疗后部分反应抗生素治疗。根据这些初步数据,我们提出了一种新的治疗算法来区分完全难治性腹膜炎和部分难治性腹膜炎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Simultaneous removal and replacement of the peritoneal catheter in PD patients with partial refractory peritonitis.

In patients on peritoneal dialysis (PD) peritonitis continues to be the main cause of PD-related death, and the leading reason of transfer to hemodialysis (HD). International guidelines recommend that peritoneal catheter should be removed if PD effluent does not clear after 5 days of adequate antibiotics defining the case as refractory peritonitis. The simultaneous removal and replacement of the peritoneal catheter (SCR) has been used as treatment for recurrent or catheter-related peritonitis after the utter healing of the acute infection to spare patient the interruption of PD and the transfer to HD. On the other hand, in case of refractory episodes the employment of SCR is discouraged. However, the clinical trend of refractory peritonitis is not homogenous: some episodes are totally unresponsive to medical therapy, while others show to be partially responsive. Thus, the treatment should be diversified according to the different clinical evolution. We report two cases of refractory peritonitis sustained by P. aeruginosa that were successfully treated by SCR after a partial response to antibiotic therapy. Along with these preliminary data, we propose a novel therapeutical algorithm differentiating between complete refractory peritonitis and partial refractory peritonitis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Vascular Access
Journal of Vascular Access 医学-外周血管病
CiteScore
3.40
自引率
31.60%
发文量
181
审稿时长
6-12 weeks
期刊介绍: The Journal of Vascular Access (JVA) is issued six times per year; it considers the publication of original manuscripts dealing with clinical and laboratory investigations in the fast growing field of vascular access. In addition reviews, case reports and clinical trials are welcome, as well as papers dedicated to more practical aspects covering new devices and techniques. All contributions, coming from all over the world, undergo the peer-review process. The Journal of Vascular Access is divided into independent sections, each led by Editors of the highest scientific level: • Dialysis • Oncology • Interventional radiology • Nutrition • Nursing • Intensive care Correspondence related to published papers is also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信